Probucol enhances the therapeutic efficiency of mesenchymal stem cells in the treatment of erectile dysfunction in diabetic rats by prolonging their survival time via Nrf2 pathway

BACKGROUND: Intracavernous injection of mesenchymal stem cells (MSCs) is a promising method for diabetic mellitus-induced erectile dysfunction (DMED), but short survival time of MSCs in cavernous is a fatal defect for therapy. This study investigated therapeutic efficiency and potential mechanism of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haoran, Zhang, Keqin, Ruan, Zheng, Sun, Dingqi, Zhang, Hui, Lin, Guiting, Hu, Liangliang, Zhao, Shengtian, Fu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374958/
https://www.ncbi.nlm.nih.gov/pubmed/32693824
http://dx.doi.org/10.1186/s13287-020-01788-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374958/
https://www.ncbi.nlm.nih.gov/pubmed/32693824
http://dx.doi.org/10.1186/s13287-020-01788-3

Ejemplares similares